Meeting ReportGYN
PET imaging of PARP-inhibitor drug-target engagement predicts response in ovarian cancer in a pilot study
Austin Pantel, Mehran Makvandi, Hyoung Kim, Joanna Weeks, Drew Torigian, Nawar Latif, Lainie Martin, Janos Tanyi, Mark Morgan, Robert Doot, Lilie Lin, David Mankoff, Robert Mach and Fiona Simpkins
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2486;
Austin Pantel
1University of Pennsylvania Health System
Mehran Makvandi
2University of Pennsylvania
Hyoung Kim
2University of Pennsylvania
Joanna Weeks
1University of Pennsylvania Health System
Drew Torigian
Nawar Latif
2University of Pennsylvania
Lainie Martin
2University of Pennsylvania
Janos Tanyi
2University of Pennsylvania
Mark Morgan
2University of Pennsylvania
Robert Doot
2University of Pennsylvania
Lilie Lin
3The University of Texas MD Anderson Cancer Center
David Mankoff
1University of Pennsylvania Health System
Robert Mach
Fiona Simpkins
4Hospital of the University of Pennsylvania

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
PET imaging of PARP-inhibitor drug-target engagement predicts response in ovarian cancer in a pilot study
Austin Pantel, Mehran Makvandi, Hyoung Kim, Joanna Weeks, Drew Torigian, Nawar Latif, Lainie Martin, Janos Tanyi, Mark Morgan, Robert Doot, Lilie Lin, David Mankoff, Robert Mach, Fiona Simpkins
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2486;
PET imaging of PARP-inhibitor drug-target engagement predicts response in ovarian cancer in a pilot study
Austin Pantel, Mehran Makvandi, Hyoung Kim, Joanna Weeks, Drew Torigian, Nawar Latif, Lainie Martin, Janos Tanyi, Mark Morgan, Robert Doot, Lilie Lin, David Mankoff, Robert Mach, Fiona Simpkins
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2486;
Jump to section
Related Articles
- No related articles found.